Jefferies analyst Kevin Grundy raised his price target for Constellation Brands (STZ) to $275 from $267 to reflect the amended Canopy Growth (CGC) warrants held by the company, which was announced with Canopy's proposed acquisition of Acerage. Constellation agreed to waive its veto rights on the deal, subject to "favorably" modified warrant terms, which enhances the company's value in return for potential dilution from the deal and provides capital flexibility, Grundy tells investors in a research note. Constellation remains his top pick with a Buy rating.

In this week's "Rising High," The Fly's recurring series focused on cannabis and psychedelic stock news, The Fly looks back on study dosing, a completed acquisition and a research partnership. ATAI ANNOUNCES DOSING... To see the rest of the story go to thefly.com. See Story Here